Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSNI
4426
CALL
DELISTED
HSN, Inc.
HSNI
| $1.05M | ﹤0.01% |
26,100
-5,700
| -18% | -$225K |
|
4427
Modine Manufacturing
MOD
$10.1B
| $1.05M | ﹤0.01% |
52,058
+4,041
| +8% | +$86.8K |
|
4428
CALL
Unilever
UL
$135B
| $1.05M | ﹤0.01% |
16,889
-7,111
| -30% | -$451K |
|
4429
Tootsie Roll Industries
TR
$2.97B
| $1.05M | ﹤0.01% |
37,609
+28,593
| +317% | +$800K |
|
4430
PUT
Synopsys
SNPS
$78.8B
| $1.05M | ﹤0.01% |
12,300
+9,300
| +310% | +$805K |
|
4431
S&T Bancorp
STBA
$1.79B
| $1.05M | ﹤0.01% |
26,315
-17,440
| -40% | -$706K |
|
4432
CALL
Primerica
PRI
$9.65B
| $1.05M | ﹤0.01% |
10,300
-7,100
| -41% | -$677K |
|
4433
CALL
Qualys
QLYS
$6.43B
| $1.04M | ﹤0.01% |
17,600
+11,800
| +203% | +$663K |
|
|
IMGN
4434
DELISTED
Immunogen Inc
IMGN
| $1.04M | ﹤0.01% |
162,949
-36,890
| -18% | -$228K |
|
|
OCLR
4435
CALL
DELISTED
Oclaro Inc.
OCLR
| $1.04M | ﹤0.01% |
155,000
+37,800
| +32% | +$279K |
|
4436
BJ's Restaurants
BJRI
$1.46B
| $1.04M | ﹤0.01% |
28,678
-593,104
| -95% | -$19.8M |
|
4437
CALL
ProShares UltraShort Gold
GLL
$103M
| $1.04M | ﹤0.01% |
3,775
+850
| +29% | +$245K |
|
|
INC
4438
DELISTED
ISHARES U S ETF TRFXD INCOME BALANCED RISK ETF (DE)
INC
| $1.04M | ﹤0.01% |
10,426
+5,534
| +113% | +$554K |
|
4439
PUT
Core Laboratories
CLB
$561M
| $1.04M | ﹤0.01% |
9,500
-12,500
| -57% | -$1.25M |
|
4440
VanEck Pharmaceutical ETF
PPH
$1B
| $1.04M | ﹤0.01% |
17,512
-998
| -5% | -$57.2K |
|
4441
Forrester Research
FORR
$221M
| $1.04M | ﹤0.01% |
23,501
-727
| -3% | -$32.6K |
|
|
OA
4442
PUT
DELISTED
Orbital ATK, Inc.
OA
| $1.04M | ﹤0.01% |
7,900
-2,700
| -25% | -$358K |
|
|
BEAT
4443
CALL
DELISTED
BioTelemetry, Inc.
BEAT
| $1.04M | ﹤0.01% |
34,700
-1,600
| -4% | -$46.3K |
|
4444
CALL
Carter's
CRI
$1.48B
| $1.03M | ﹤0.01% |
8,800
+2,900
| +49% | +$300K |
|
|
COBZ
4445
DELISTED
CoBiz Financial,Inc
COBZ
| $1.03M | ﹤0.01% |
51,716
+1,125
| +2% | +$22.8K |
|
|
KND
4446
DELISTED
Kindred Healthcare
KND
| $1.03M | ﹤0.01% |
106,509
-643,361
| -86% | -$4.79M |
|
|
POT
4447
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.03M | ﹤0.01% |
50,047
-113,936
| -69% | -$2.21M |
|
4448
CALL
Teucrium Corn Fund
CORN
$165M
| $1.03M | ﹤0.01% |
61,400
+14,100
| +30% | +$241K |
|
4449
Travel + Leisure Co
TNL
$4.5B
| $1.03M | ﹤0.01% |
19,669
-51,005
| -72% | -$2.53M |
|
|
CBM
4450
DELISTED
Cambrex Corporation
CBM
| $1.03M | ﹤0.01% |
21,435
-59,569
| -74% | -$2.95M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.